Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Beta-Blocker Heart Attack Trial (BHAT)
This study has been completed.
Study NCT00000492 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arrhythmia
Cardiovascular Diseases
Coronary Disease
Death, Sudden, Cardiac
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
Ventricular Fibrillation
Additional conditions recognized in this trial
Arrhythmias, Cardiac
Coronary Artery Disease
Death, Sudden
Infarction
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Death
Heart Arrest
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
propranolol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
